Oral Nalbuphine Extended-Release Is Effective in Severe Prurigo Nodularis–Associated Pruritus: Results From a Phase 2b/3, Double-Blind, Placebo-Controlled Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s103, 2022. DOI: 10.25251/skin.6.supp.103. Disponível em: https://skin.dermsquared.com/skin/article/view/1862. Acesso em: 19 apr. 2025.